

ADVERTISEMENT
ADVERTISEMENT

Maintenance #Rituximab vs Retreatment Rituximab in Patients with Low–Tumor-Burden Follicular #Lymphoma http://t.co/n3GZnXAh #hematology
about 12 hours ago via web
AVEREL Trial Shows Benefit of #Bevacizumab in #HER2-positive Locally Recurrent or Metastatic #BreastCancer http://t.co/5GjE2V1T
about 15 hours ago via web
#FDA announces major actions taken to bolster the supply of #Doxil and preservative-free formulations of #methotrexate http://t.co/bPU8O0h7
about 1 days ago via web
JAK2 and MPL #Mutation #Screening: What Are the Indications and How to Interpret the Results http://t.co/npbhBSE4 #cancer #hematology
about 1 days ago via web
RT @TedOkonCOA: Votes today on tax package containing Medicare #SGR 10-mo patch. Medicare cuts paying for Medicare patch. Not good.
about 5 days ago via web
about 12 hours ago via web
AVEREL Trial Shows Benefit of #Bevacizumab in #HER2-positive Locally Recurrent or Metastatic #BreastCancer http://t.co/5GjE2V1T
about 15 hours ago via web
#FDA announces major actions taken to bolster the supply of #Doxil and preservative-free formulations of #methotrexate http://t.co/bPU8O0h7
about 1 days ago via web
JAK2 and MPL #Mutation #Screening: What Are the Indications and How to Interpret the Results http://t.co/npbhBSE4 #cancer #hematology
about 1 days ago via web
RT @TedOkonCOA: Votes today on tax package containing Medicare #SGR 10-mo patch. Medicare cuts paying for Medicare patch. Not good.
about 5 days ago via web








